Yong Q. Fang

180 Fenglin Road
Zhongshan, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 244 publications

Osimertinib With or Without Chemotherapy in Advanced Non-Small Cell Lung Cancer With EGFR and Concurrent TP53 Mutations: A Randomized Clinical Trial.

Osimertinib With or Without Chemotherapy in Advanced Non-Small Cell Lung Cancer With EGFR and Concurrent TP53 Mutations: A Randomized Clinical Trial.

Journal: JAMA
Published: August 10, 2026

Efficacy of insulin application in skin wound healing: a systematic review and meta-analysis.

Efficacy of insulin application in skin wound healing: a systematic review and meta-analysis.

Journal: Journal of wound care
Published: June 09, 2026

Sacituzumab tirumotecan plus pembrolizumab versus pembrolizumab in PD-L1-positive advanced non-small-cell lung cancer (OptiTROP-Lung05): interim analysis of a randomised, open-label, phase 3 trial.

Sacituzumab tirumotecan plus pembrolizumab versus pembrolizumab in PD-L1-positive advanced non-small-cell lung cancer (OptiTROP-Lung05): interim analysis of a randomised, open-label, phase 3 trial.

Journal: Lancet (London, England)
Published: April 22, 2026

Trastuzumab Deruxtecan in Patients From China With Pretreated HER2-Mutant Non-Small Cell Lung Cancer: Final Analysis of the Phase 2, Single-Arm DESTINY-Lung05 Trial.

Trastuzumab Deruxtecan in Patients From China With Pretreated HER2-Mutant Non-Small Cell Lung Cancer: Final Analysis of the Phase 2, Single-Arm DESTINY-Lung05 Trial.

Journal: Clinical lung cancer
Published: March 20, 2026

Expert consensus on the detection and clinical application of tumor mutational burden.

Expert consensus on the detection and clinical application of tumor mutational burden.

Journal: Cancer biology & medicine
Published: February 18, 2026

A hydro-topological strategy enables self-regulating biofilms for sustainable wastewater treatment.

A hydro-topological strategy enables self-regulating biofilms for sustainable wastewater treatment.

Journal: Nature communications
Published: November 12, 2025

Sacituzumab Tirumotecan in EGFR-TKI-Resistant, EGFR-Mutated Advanced NSCLC.

Sacituzumab Tirumotecan in EGFR-TKI-Resistant, EGFR-Mutated Advanced NSCLC.

Journal: The New England journal of medicine
Published: October 22, 2025

Sevabertinib in Advanced HER2-Mutant Non-Small-Cell Lung Cancer.

Sevabertinib in Advanced HER2-Mutant Non-Small-Cell Lung Cancer.

Journal: The New England journal of medicine
Published: October 17, 2025

Integrative Multiomics and Network Pharmacology Exploration of Active Components and Mechanisms of Action of Qufu Shengxin Ointment in Treating Chronic Nonhealing Wounds.

Integrative Multiomics and Network Pharmacology Exploration of Active Components and Mechanisms of Action of Qufu Shengxin Ointment in Treating Chronic Nonhealing Wounds.

Journal: Mediators of inflammation
Published: September 17, 2025

Garsorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: A pooled analysis of phase 1/2 study.

Garsorasib in patients with KRAS G12C-mutated non-small-cell lung cancer: A pooled analysis of phase 1/2 study.

Journal: European journal of cancer (Oxford, England : 1990)
Published: August 22, 2025

An integrated analysis of lactylation signature reveals PRDX1 as a therapeutic target of keloid pathogenesis.

An integrated analysis of lactylation signature reveals PRDX1 as a therapeutic target of keloid pathogenesis.

Journal: Scientific reports
Published: August 21, 2025

Intracranial Efficacy of Crizotinib and Postprogression Therapeutic Strategies in Advanced c-ros Oncogene 1 (ROS1)-Positive Non-Small Cell Lung Cancer (NSCLC), a Multicenter Real-World Study.

Intracranial Efficacy of Crizotinib and Postprogression Therapeutic Strategies in Advanced c-ros Oncogene 1 (ROS1)-Positive Non-Small Cell Lung Cancer (NSCLC), a Multicenter Real-World Study.

Journal: MedComm
Published: July 30, 2025
Showing 1-12 of 244

Last Updated: 09/26/2026